Abstract
Forty-six Yersinia enterocolitica O:3 clinical isolates resistant to nalidixic acid were studied. The use of molecular typing techniques, other indicators of resistance patterns, the plasmid profile, and the presence of genes that encode aminoglycoside-modifying enzyme production suggested to us a clonal dissemination of the studied strains.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Infective Agents / pharmacology*
-
Drug Resistance, Bacterial* / genetics
-
Humans
-
Microbial Sensitivity Tests
-
Nalidixic Acid / pharmacology*
-
Nucleotidyltransferases / genetics
-
Plasmids / genetics
-
Yersinia Infections / epidemiology*
-
Yersinia Infections / microbiology
-
Yersinia enterocolitica / drug effects*
-
Yersinia enterocolitica / genetics
Substances
-
Anti-Infective Agents
-
Nalidixic Acid
-
Nucleotidyltransferases
-
streptomycin 3''-adenylyltransferase